An updated review on pulsatile drug delivery system

Pulsatile Drug Delivery Systems are gaining a lot of interest as they deliver the drug at the right place, at the right time and in the right amount, thus providing spatial, temporal and smart delivery and increasing patient compliance. The use of pulsatile release of the drugs is desirable where constant drug release is not desired. PDDS can be classified into time controlled systems wherein the drug release is controlled primarily by the delivery system; stimuli induced PDDS in which release is controlled by the stimuli, like the pH or enzymes present in the intestinal tract or enzymes present in the drug delivery system and externally regulated system where release is programmed by external stimuli like magnetism, ultrasound, electrical effect and irradiation. The current article focuses on the diseases requiring PDDS, methodologies involved for the existing systems, current situation and future scope, recent advances in PDDS and PDDS product currently available in the market.

[1]  B. Lemmer The clinical relevance of chronopharmacology in therapeutics. , 1996, Pharmacological research.

[2]  P. Kleinebudde,et al.  A new multiparticulate delayed release system.: Part I: Dissolution properties and release mechanism , 1997 .

[3]  K. Reddy,et al.  REVIEW ON: PULSATILE DRUG DELIVERY SYSTEMS , 2009 .

[4]  B. Youan,et al.  Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Roland Zengerle,et al.  Discrete Chemical Release From a microfluidic Chip , 2006 .

[6]  Teruo Okano,et al.  Thermally on-off switching polymers for drug permeation and release , 1990 .

[7]  A. Khopade,et al.  ORAL PULSATILE DRUG DELIVERY , 1996 .

[8]  N. Bellamy,et al.  Rhythmic variations in pain perception in osteoarthritis of the knee. , 1990, The Journal of rheumatology.

[9]  R. Parikh,et al.  Pulsatile Drug Delivery Systems: An Overview , 2011 .

[10]  A. Pawar,et al.  Low density multiparticulate system for pulsatile release of meloxicam. , 2006, International journal of pharmaceutics.

[11]  K. Horch,et al.  Biocompatibility of silicon-based electrode arrays implanted in feline cortical tissue. , 1993, Journal of biomedical materials research.

[12]  R M Ellis,et al.  Circadian variation in disease activity in rheumatoid arthritis. , 1982, British medical journal.

[13]  S. Mutalik,et al.  Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[14]  K. Schlüter,et al.  Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. , 2000, American journal of physiology. Cell physiology.

[15]  A. Gazzaniga,et al.  Oral pulsatile delivery: rationale and chronopharmaceutical formulations. , 2010, International journal of pharmaceutics.

[16]  P. Revell,et al.  Diamond-like carbon applied to bioengineering materials , 1991 .

[17]  T. Okano,et al.  “On–Off” Thermocontrol of Solute Transport. I. Temperature Dependence of Swelling of N-Isopropylacrylamide Networks Modified with Hydrophobic Components in Water , 1991, Pharmaceutical Research.

[18]  R. Pownall,et al.  Circadian variation in disease activity in rheumatoid arthritis. , 1982, British medical journal.

[19]  S. Barhate,et al.  PULSATILE DRUG DELIVERY SYSTEM: A REVIEW , 2015 .

[20]  A. Gazzaniga,et al.  Oral delayed-release system for colonic specific delivery☆ , 1994 .

[21]  S. Suresh,et al.  Chronotherapeutics : Emerging role of biorhythms in optimizing drug therapy , 2005 .

[22]  A. Reinberg,et al.  Tenoxicam chronotherapy of rheumatic diseases , 1990 .